Mitochondrial transcription factor A variants and the risk of Parkinson's disease

Neuroscience Letters
Katarzyna Gaweda-WalerychCezary Zekanowski

Abstract

The mitochondrial transcription factor A (TFAM) has been recently shown to decrease reactive oxygen species (ROS) generation. It is also known that mitochondrial DNA (mtDNA) haplogroups might confer different coupling properties, resulting in different ROS levels. We hypothesized that potentially functional TFAM variants could influence PD risk depending on haplogroup background. To test this we assessed the role of six TFAM variants on PD risk in 326 PD patients and 316 controls, and correlated it with mtDNA haplogroup clusters (HV, JTKU and a putative functionally different group U4U5a1KJ1cJ2, connected previously with partial uncoupling of oxidative phosphorylation). Both genotype and haplotype analysis showed that intronic variant rs2306604 modifies PD risk. Multivariate logistic regression analysis confirmed that rs2306604 G/G genotype is an independent risk factor for PD (OR 1.789, 95% CI 1.162-2.755, p=0.008). There was a borderline interaction between G/G genotype and HV haplogroup (p=0.075). Haplotype analysis showed that all three haplotypes containing rs2306604 allele A occurred at higher frequencies in controls, but only one of them reached statistical significance (chi(2) 4.523, p=0.0334). Conversely, four of five ...Continue Reading

References

Aug 26, 1998·Human Mutation·P K RoganT D Schneider
Feb 16, 2002·Bioinformatics·Hideo BannaiSatoru Miyano
Jul 20, 2002·Biochemical and Biophysical Research Communications·Yoichiro YoshidaKimitoshi Kohno
Mar 6, 2003·American Journal of Human Genetics·Joelle M van der WaltJeffery M Vance
Mar 11, 2003·Nucleic Acids Research·Tanfis Istiaq AlamDongchon Kang
Jan 13, 2004·Science·Eduardo Ruiz-PesiniDouglas C Wallace
Mar 19, 2005·Human Mutation·Vijay K Nalla, Peter K Rogan
Mar 24, 2005·Annals of Neurology·Angela PylePatrick F Chinnery
Apr 14, 2005·European Journal of Human Genetics : EJHG·Daniele GhezziMassimo Zeviani
Sep 13, 2005·Trends in Genetics : TIG·Anna Di Rienzo, Richard R Hudson
Oct 28, 2005·American Journal of Human Genetics·Demetrius M MaraganoreDennis G Ballinger
Dec 6, 2005·Gene·Francisco Montiel-SosaManuel José López-Pérez
Jan 28, 2006·Biochimica Et Biophysica Acta·Heiko NoackMarten Szibor
Feb 2, 2006·Human Molecular Genetics·Yukiko KurodaToshio Matsumoto
Feb 24, 2006·Nature Reviews. Neuroscience·Patrick M Abou-SleimanNicholas W Wood
Jan 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Mats I EkstrandNils-Göran Larsson
Jun 19, 2007·PLoS Genetics·Jeremy HullDominic Kwiatkowski
Nov 22, 2007·The FEBS Journal·Viktoriya PastukhMikhail Alexeyev
Feb 6, 2008·Neuroscience Letters·Victoria AlvarezEliecer Coto
Mar 1, 2008·Neurobiology of Aging·Aleksandra MaruszakMaria Barcikowska
Aug 22, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yoshinori HayashiHiroshi Nakanishi
Sep 24, 2008·Journal of Neural Transmission·Katarzyna Gaweda-WalerychCezary Zekanowski

❮ Previous
Next ❯

Citations

Feb 15, 2011·Parkinson's Disease·A R EstevesS M Cardoso
Apr 5, 2011·Parkinson's Disease·P C KeaneC M Morris
Aug 26, 2014·Journal of the Neurological Sciences·Sasan AndalibAlbert Gjedde
Jan 19, 2016·The American Journal of Pathology·Marta BlanchMarta Barrachina
Jul 19, 2011·Mutation Research·Ester López-GallardoEduardo Ruiz-Pesini
Sep 18, 2015·Proceedings. Biological Sciences·Daniel B SloanJustin C Havird
Jan 22, 2013·Current Opinion in Structural Biology·Anna Rubio-Cosials, Maria Solà
Dec 28, 2010·Free Radical Biology & Medicine·Lauren BroomDavid T Dexter
Mar 1, 2012·Parkinsonism & Related Disorders·Katarzyna Gaweda-WalerychCezary Zekanowski
Nov 3, 2011·Biochimica Et Biophysica Acta·Dan Bar-YaacovDan Mishmar
Oct 25, 2016·Neurobiology of Aging·K Gaweda-WalerychE Buratti
Nov 23, 2016·CNS Neuroscience & Therapeutics·Mojtaba GolpichAbolhassan Ahmadiani
Sep 27, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Johannes J GaareCharalampos Tzoulis
May 14, 2020·DNA and Cell Biology·Rebeca Martín-JiménezEtienne Hebert-Chatelain
May 12, 2018·Current Opinion in Neurology·Irene H Flønes, Charalampos Tzoulis
Jan 30, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Amica C Müller-NedebockSoraya Bardien
May 22, 2021·Journal of Cellular and Molecular Medicine·Masoud BaghiKamran Ghaedi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.